Taku Yasui

1.0k total citations
30 papers, 636 citations indexed

About

Taku Yasui is a scholar working on Cardiology and Cardiovascular Medicine, Pulmonary and Respiratory Medicine and Oncology. According to data from OpenAlex, Taku Yasui has authored 30 papers receiving a total of 636 indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Cardiology and Cardiovascular Medicine, 9 papers in Pulmonary and Respiratory Medicine and 8 papers in Oncology. Recurrent topics in Taku Yasui's work include Venous Thromboembolism Diagnosis and Management (6 papers), Chemotherapy-induced cardiotoxicity and mitigation (6 papers) and Cardiac tumors and thrombi (4 papers). Taku Yasui is often cited by papers focused on Venous Thromboembolism Diagnosis and Management (6 papers), Chemotherapy-induced cardiotoxicity and mitigation (6 papers) and Cardiac tumors and thrombi (4 papers). Taku Yasui collaborates with scholars based in Japan, United States and China. Taku Yasui's co-authors include Issei Komuro, Toru Oka, Wataru Shioyama, Yoshikazu Nakaoka, Takashi Morita, Masatake Fukunami, Yuji Okuyama, Takahisa Yamada, Yasushi Sakata and Keiko Yamauchi‐Takihara and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Circulation and SHILAP Revista de lepidopterología.

In The Last Decade

Taku Yasui

26 papers receiving 628 citations

Peers

Countries citing papers authored by Taku Yasui

Since Specialization

Citations

This map shows the geographic impact of Taku Yasui's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Taku Yasui with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Taku Yasui more than expected).

Fields of papers citing papers by Taku Yasui

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Taku Yasui. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Taku Yasui. The network helps show where Taku Yasui may publish in the future.

Co-authorship network of co-authors of Taku Yasui

This figure shows the co-authorship network connecting the top 25 collaborators of Taku Yasui. A scholar is included among the top collaborators of Taku Yasui based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Taku Yasui. Taku Yasui is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Immune checkpoint inhibitor-related myocarditis during DUO-E regimen for endometrial cancer: The first case report in gynecologic oncology 2025 ·Gynecologic Oncology Reports ·(unknown), Hironori Yamamoto, (unknown), Taku Yasui, Masashi Fujita, (unknown), (unknown)	0
2	Tenascin-C as a potential marker for immunohistopathology of doxorubicin-induced cardiomyopathy 2023 ·European Heart Journal Open ·Tatsuya Nishikawa, (unknown), Yoshihiko Ikeda, Keiko Ohta‐Ogo, Takumi Kondo, (unknown), Toru Oka, Wataru Shioyama, Hironori Yamamoto, Taku Yasui, Yoshiharu Higuchi, Hatsue Ishibashi‐Ueda, Keiichiro Honma, Chisato Izumi, Shuichiro Higo, Kinta Hatakeyama, Yasushi Sakata, Masashi Fujita	0
3	A Case of Lung Cancer with Very-Late-Onset Immune Checkpoint Inhibitor-Related Myocarditis 2022 ·CJC Open ·Tatsuya Nishikawa, Motohiro Tamiya, Keiko Ohta‐Ogo, Yoshihiko Ikeda, Kinta Hatakeyama, Keiichiro Honma, Taku Yasui, Wataru Shioyama, Toru Oka, Takako Inoue, Toru Kumagai, Masashi Fujita	3
4	Sinus Node Dysfunction Co-occurring with Immune Checkpoint Inhibitor-associated Myocarditis 2022 ·Internal Medicine ·Tatsuya Nishikawa, (unknown), Keiko Ohta‐Ogo, Yoshihiko Ikeda, Taku Yasui, Wataru Shioyama, Toru Oka, Keiichiro Honma, Kinta Hatakeyama, Toru Kumagai, Masashi Fujita	9
5	Prevalence and characteristics of immune checkpoint inhibitor-related myocardial damage: A prospective observational study 2022 ·PLoS ONE ·Tatsuya Nishikawa, Takako Inoue, Tomoyuki Otsuka, (unknown), Yoji Kukita, Harumi Nakamura, Yoshihiko Ikeda, Taku Yasui, Wataru Shioyama, Toru Oka, (unknown), Kinta Hatakeyama, Hiroshi Miyata, Taiki Isei, Ryu Ishihara, Toru Kumagai, Kazuo Nishimura, Masashi Fujita	7
6	Multicentre cohort study of the impact of percutaneous coronary intervention on patients with concurrent cancer and ischaemic heart disease 2021 ·BMC Cardiovascular Disorders ·Tatsuya Nishikawa, Toshitaka Morishima, Sumiyo Okawa, Yuki Fujii, Tomoyuki Otsuka, Toshihiro Kudo, Takeshi Fujita, (unknown), Taku Yasui, Wataru Shioyama, Toru Oka, Takahiro Tabuchi, Masashi Fujita, Isao Miyashiro	7
7	Acute myocardial infarction caused by tumor embolus originating from upper tract urothelial carcinoma: a case report 2020 ·Cardio-Oncology ·Taku Yasui, (unknown), Wataru Shioyama, Toru Oka, Tatsuya Nishikawa, (unknown), Koji Hatano, Kazuo Nishimura, Masashi Fujita	0
8	Cardiac Adverse Events in EGFR-Mutated Non-Small Cell Lung Cancer Treated With Osimertinib 2020 ·JACC CardioOncology ·Kei Kunimasa, (unknown), Toru Oka, Makiko Oboshi, Madoka Kimura, Takako Inoue, Motohiro Tamiya, Tatsuya Nishikawa, Taku Yasui, Wataru Shioyama, Kazumi Nishino, Fumio Imamura, Toru Kumagai, Masashi Fujita	58
9	Coronary spastic angina in a multiple myeloma patient treated with bortezomib, lenalidomide, and dexamethasone 2020 ·Journal of Cardiology Cases ·Taku Yasui, Wataru Shioyama, Makiko Oboshi, Tatsuya Nishikawa, (unknown), Toru Oka, Masashi Fujita	2
10	Single-drug approach with rivaroxaban: A case of successful anticoagulation against cancer-associated thrombosis 2019 ·Journal of Cardiology Cases ·Wataru Shioyama, Toru Oka, Taku Yasui, Masashi Fujita	2
11	Irreversible severe cardiotoxicities except for QTc interval prolongation associated with Osimertinib 2019 ·Annals of Oncology ·Kei Kunimasa, Madoka Kimura, Makiko Oboshi, Takako Inoue, Motohiro Tamiya, Hanako Kuhara, Kazumi Nishino, Taku Yasui, Wataru Shioyama, Masashi Fujita, Fumio Imamura, Toru Kumagai	1
12	Fracture of a Retrievable Inferior Vena Cava Filter Placed for Cancer-associated Thrombosis in a Patient with Malignant Lymphoma 2019 ·Internal Medicine ·Tatsuya Nishikawa, Toru Oka, Wataru Shioyama, (unknown), Taku Yasui, Makiko Oboshi, (unknown), Masashi Fujita	3
13	Aortic Dissection and Cardiac Dysfunction Emerged Coincidentally During the Long-Term Treatment with Angiogenesis Inhibitors for Metastatic Renal Cell Carcinoma 2018 ·International Heart Journal ·(unknown), Taku Yasui, Toru Oka, Wataru Shioyama, Tadashi Kuroda, Yasutomo Nakai, Kazuo Nishimura, Mikio Mukai, Masashi Fujita	26
14	Molecular Characterization of Striated Muscle-Specific Gab1 Isoform as a Critical Signal Transducer for Neuregulin-1/ErbB Signaling in Cardiomyocytes 2016 ·PLoS ONE ·Taku Yasui, Takeshi Masaki, Yoh Arita, Tomohiko Ishibashi, Tadakatsu Inagaki, Makoto Okazawa, Toru Oka, Wataru Shioyama, Keiko Yamauchi‐Takihara, Issei Komuro, Yasushi Sakata, Yoshikazu Nakaoka	4
15	Interleukin-6/interleukin-21 signaling axis is critical in the pathogenesis of pulmonary arterial hypertension 2015 ·Proceedings of the National Academy of Sciences ·(unknown), Naoki Hosen, Takashi Sonobe, Yoh Arita, Taku Yasui, Takeshi Masaki, Masato Minami, Tadakatsu Inagaki, Shigeru Miyagawa, Yoshiki Sawa, Masaaki Murakami, Atsushi Kumanogoh, Keiko Yamauchi‐Takihara, Meinoshin Okumura, Tadamitsu Kishimoto, Issei Komuro, Mikiyasu Shirai, Yasushi Sakata, Yoshikazu Nakaoka	186
16	Abstract 15664: Angiopoietin-1 Derived From Vascular Smooth Muscle Cells is Essential for Arteriogenesis After Hindlimb Ischemia 2014 ·Circulation ·Kuniyasu Ikeoka, Yoshikazu Nakaoka, Yoh Arita, Takahiro Hashimoto, Taku Yasui, Takeshi Masaki, Keiko Yamauchi‐Takihara, Mikiyasu Shirai, Issei Komuro, Yasushi Sakata	1
17	TOCILIZUMAB AMELIORATES VASCULAR INFLAMMATION AND CLINICAL SYMPTOMS IN PATIENTS WITH TAKAYASU ARTERITIS REFRACTOTRY TO GLUCOCORTICOIDS 2013 ·Journal of the American College of Cardiology ·Yoshikazu Nakaoka, (unknown), Yoh Arita, Takahiro Kataoka, Taku Yasui, Kuniyasu Ikeoka, Tomohito Ohtani, Yasushi Sakata, Keiko Yamauchi‐Takihara, Issei Komuro	2
18	Usefulness of Cardiac Iodine-123 Meta-Iodobenzylguanidine Imaging to Improve Prognostic Power of Seattle Heart Failure Model in Patients With Chronic Heart Failure 2011 ·The American Journal of Cardiology ·Yuki Kuramoto, Takahisa Yamada, Shunsuke Tamaki, Yuji Okuyama, Takashi Morita, Yoshio Furukawa, Kõji Tanaka, Yusuke Iwasaki, Taku Yasui, Hiromichi Ueda, Takeshi Okada, Masato Kawasaki, Wayne C. Levy, Issei Komuro, Masatake Fukunami	22
19	Cardiac Iodine-123 Metaiodobenzylguanidine Imaging Predicts Sudden Cardiac Death Independently of Left Ventricular Ejection Fraction in Patients With Chronic Heart Failure and Left Ventricular Systolic Dysfunction 2009 ·Journal of the American College of Cardiology ·Shunsuke Tamaki, Takahisa Yamada, Yuji Okuyama, Takashi Morita, Shoji Sanada, Yasumasa Tsukamoto, Masaharu Masuda, Keiji Okuda, Yusuke Iwasaki, Taku Yasui, Masatsugu Hori, Masatake Fukunami	155
20	Sodium Bicarbonate Improves Long-Term Clinical Outcomes Compared With Sodium Chloride in Patients With Chronic Kidney Disease Undergoing an Emergent Coronary Procedure 2008 ·Circulation Journal ·Masaharu Masuda, Takahisa Yamada, Yuji Okuyama, Takashi Morita, Shoji Sanada, Yoshio Furukawa, Yasumasa Tsukamoto, Keiji Okuda, (unknown), Taku Yasui, Masatake Fukunami	13

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact